ADMA Biologics Inc.
ADMA | NASDAQ
$9.51
+$0.40 (+4.39%)
At close: Sep 21, 2026, 4:00 PM ET
$9.49
-$0.02 (-0.21%)
Pre-market:
Sep 22, 2026, 8:18 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 136.02M | 138.15M | 87.63M | 61.39M | 90.29M | 71.63M | 103.15M | 86.71M | 88.24M | 45.33M | 51.35M | 74.16M | 62.51M | 69.2M | 86.52M | 34.91M | 52.42M | 69.5M | 51.09M | 34.41M | 42.41M | 61.97M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 9.13M | 8.47M | 8.6M | 8.8M | 9.06M | 8.19M | 5.66M | 14.72M | 5.22M | 5.89M | 4.67M | 6.72M | 6.29M | 4.72M | 4.77M | 4.46M | 3.76M | 2.83M | 4.07M | 3.33M | 2.53M | 2.22M |
Receivables | 138.23M | 135.86M | 158.43M | 137.67M | 109.73M | 99.41M | 50M | 50.14M | 30.11M | 49.62M | 27.42M | 31.32M | 36.73M | 26.52M | 15.51M | 20.9M | 18.88M | 25.63M | 28.58M | 20.39M | 23.54M | 15.36M |
Inventory | 239.31M | 222.1M | 206.47M | 196.67M | 191.46M | 172.19M | 170.24M | 171.8M | 179.81M | 177.73M | 172.91M | 163.12M | 161.78M | 163.98M | 163.28M | 162.91M | 146.08M | 139.15M | 124.72M | 114.12M | 99.7M | 94.15M |
Other Current Assets | n/a | 15.06M | 13.99M | 6.93M | 8.09M | 8.59M | 8.03M | 9.55M | 5.52M | 3.74M | 5.33M | 5.11M | 5.22M | 4.38M | 5.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 528.2M | 511.17M | 466.51M | 402.66M | 399.56M | 351.81M | 331.41M | 318.19M | 303.69M | 276.42M | 257.01M | 273.7M | 266.24M | 264.09M | 270.4M | 224.09M | 222.77M | 239.8M | 208.73M | 174.79M | 171.36M | 177.28M |
Property-Plant & Equipment | 72.81M | 71.41M | 71.71M | 78.78M | 66.46M | 65.73M | 63.34M | 53.69M | 63.48M | 64.71M | 63.47M | 64.57M | 66.31M | 67.62M | 68.75M | 67.28M | 65.5M | 60.33M | 58.2M | 55.08M | 53.32M | 50.37M |
Goodwill & Intangibles | 4.11M | 4.16M | 4.16M | 4.02M | 4.06M | 3.98M | 3.99M | 4.02M | 4.01M | 3.85M | 4.03M | 4.01M | 4.19M | 4.36M | 4.54M | 4.72M | 4.9M | 5.08M | 5.26M | 5.44M | 5.62M | 5.79M |
Total Long-Term Assets | 156.01M | 154.01M | 157.73M | 166.03M | 158.82M | 158.76M | 157.27M | 72.43M | 72.71M | 74.46M | 72.17M | 75.3M | 76.78M | 76.7M | 78.06M | 76.46M | 74.16M | 68.23M | 67.52M | 63.86M | 61.46M | 58.39M |
Total Assets | 684.21M | 665.18M | 624.24M | 568.69M | 558.38M | 510.57M | 488.68M | 390.62M | 376.4M | 350.88M | 329.18M | 349M | 343.03M | 340.79M | 348.46M | 300.56M | 296.93M | 308.03M | 276.25M | 238.64M | 232.81M | 235.67M |
Account Payables | 31.72M | 20.52M | 22.52M | 24.02M | 29.77M | 20.61M | 20.22M | 16.02M | 14.18M | 17.19M | 15.66M | 10.85M | 12.08M | 12.96M | 13.23M | 25.2M | 11.39M | 14.12M | 12.43M | 17.28M | 6.17M | 12.15M |
Deferred Revenue | n/a | n/a | n/a | n/a | 143K | 143K | 143K | 143K | 1.13M | 1.12M | 182K | 142.83K | 142.83K | 142.83K | 143K | 142.83K | 142.83K | 142.83K | 142.83K | 142.83K | 142.83K | 142.83K |
Short-Term Debt | 3.75M | 3.28M | 2.81M | 2.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 317.91K |
Other Current Liabilities | 4.78M | 3.35M | 6.82M | 2.56M | 17.49M | 2.05M | 1.85M | 3.32M | 2.29M | 2.38M | 2.37M | 2.61M | 2.2M | 2.04M | 1.8M | 2.11M | 3.03M | 3.09M | 16.05M | 2.51M | 1.94M | 6.48M |
Total Current Liabilities | 75.76M | 73.54M | 69.54M | 56.49M | 74.94M | 53.5M | 55.54M | 44.89M | 44.18M | 53.09M | 49.81M | 41.84M | 41.95M | 36.73M | 39.27M | 44.44M | 28.07M | 31.57M | 30.38M | 32.34M | 18.19M | 21.21M |
Long-Term Debt | 192.84M | 193.58M | 69.33M | 70.08M | 73.4M | 72.53M | 72.34M | 101.33M | 131.07M | 130.85M | 130.59M | 142.03M | 140.31M | 144.3M | 142.83M | 141.37M | 139.81M | 138.42M | 94.87M | 94.36M | 93.88M | 93.41M |
Other Long-Term Liabilities | n/a | n/a | n/a | 90K | 940K | 1.32M | 1.67M | 2.06M | 2.08M | 2.09M | 2.11M | 2M | 2.02M | 1.84M | 1.85M | 1.86M | 1.87M | 1.89M | 397.35K | 232.67K | 36.15K | 41.97K |
Total Long-Term Liabilities | 200.25M | 201.32M | 77.38M | 81.01M | 85.11M | 83.65M | 84.12M | 113.84M | 143.95M | 144.08M | 144.17M | 155.72M | 154.31M | 158.41M | 157.22M | 155.73M | 154.46M | 149.53M | 104.7M | 103.52M | 103.03M | 101.96M |
Total Liabilities | 276M | 274.86M | 146.92M | 137.5M | 160.06M | 137.15M | 139.66M | 158.73M | 188.13M | 197.17M | 193.98M | 197.56M | 196.26M | 195.13M | 196.49M | 200.17M | 182.53M | 181.1M | 135.08M | 135.86M | 121.22M | 123.16M |
Total Debt | 203.84M | 204.41M | 79.89M | 83.12M | 83.83M | 82.01M | 82.12M | 111.38M | 141.4M | 141.43M | 141.42M | 152.97M | 151.51M | 155.73M | 154.44M | 152.72M | 151.26M | 146.36M | 102.92M | 101.78M | 101.34M | 100.15M |
Book Value | 408.21M | 390.33M | 477.32M | 431.19M | 398.33M | 373.42M | 349.02M | 231.89M | 188.27M | 153.71M | 135.21M | 151.44M | 146.76M | 145.65M | 151.97M | 100.38M | 114.4M | 126.93M | 141.17M | 102.78M | 111.59M | 112.5M |
Book Value Per Share | 1.77 | 1.63 | 1.96 | 1.76 | 1.60 | 1.53 | 1.42 | 0.95 | 0.78 | 0.65 | 0.60 | 0.65 | 0.66 | 0.66 | 0.75 | 0.51 | 0.58 | 0.65 | 0.78 | 0.77 | 0.88 | 0.97 |
Common Stock | 24K | 24K | 24K | 24K | 24K | 24K | 24K | 24K | 23K | 23K | 23K | 22.6K | 22.45K | 22.23K | 22K | 19.68K | 19.64K | 19.64K | 19.58K | 13.83K | 13.19K | 12.3K |
Retained Earnings | -78.5M | -116.33M | -161.65M | -211.03M | -247.46M | -281.68M | -308.58M | -420.48M | -456.39M | -488.45M | -506.26M | -488.61M | -491.18M | -484.81M | -478.02M | -465.78M | -450.89M | -437.12M | -412.11M | -395.46M | -377.75M | -358.85M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 408.21M | 390.33M | 477.32M | 431.19M | 398.33M | 373.42M | 349.02M | 231.89M | 188.27M | 153.71M | 135.21M | 151.44M | 146.76M | 145.65M | 151.97M | 100.38M | 114.4M | 126.93M | 141.17M | 102.78M | 111.59M | 112.5M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ADMA